<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[collaboration and license agreement Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/collaboration+and+license+agreement.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to collaboration and license agreement]]></description>
	<s:counts start="0" returned="7" found="7" />
	<language>en-us</language>
	<item>
		<title><![CDATA[SCOLR Pharma, Inc. and Dr. Reddy's Laboratories Enter into Collaboration and License Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_23/ai_n27416173]]></link>
		<description><![CDATA[BELLEVUE, Wash. -- SCOLR Pharma, Inc. (AMEX: DDD) today announced that it has entered into a collaboration and license agreement with Dr. Reddy's Laboratories (NYSE:RDY), an emerging global pharmaceutical company. The parties will pursue the development and commercialization of an undisclosed oral prescription drug with significant potential for the cardiopulmonary...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 23 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EXACT Sciences and NorDiag Announce International Collaboration and License Agreement for Colorectal Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_5/ai_n27262503]]></link>
		<description><![CDATA[MARLBOROUGH, Mass. & OSLO, Norway -- EXACT Sciences Corporation (NASDAQ: EXAS) and NorDiag ASA (OSE: NORD) announced today that they have entered into a collaboration and a non-exclusive license agreement to advance the development and commercialization of colorectal cancer CRC screening technologies outside the U.S. and Canada. Under the terms...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Jun 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Gladstone Institutes and Merck & Co., Inc. Announce Major Research Collaboration and Exclusive License Agreement in Field of Apolipoprotein  E]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Nov_2/ai_n16853488]]></link>
		<description><![CDATA[Research Focuses on Treatment and Prevention of Alzheimer's Disease by Altering ApoE4-induced Neuronal Dysfunction]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 02 Nov 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Geron Enters into a Collaboration and License Agreement with MERCK & CO., INC. for Cancer Vaccines Targeting Telomerase]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_July_18/ai_n14792808]]></link>
		<description><![CDATA[MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) announced today it has entered into a collaboration and license agreement with Merck & Co., Inc. (NYSE:MRK) to develop a cancer vaccine targeting telomerase utilizing Merck's expertise in vaccine technologies.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 18 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Agensys Signs Collaboration and License Agreement with Genentech]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_22/ai_n6118076]]></link>
		<description><![CDATA[SANTA MONICA, Calif. -- Agensys, Inc., a cancer biotechnology company, today announced an agreement with Genentech Inc. (NYSE:DNA) for the research, development and commercialization of therapeutic and diagnostic products to two of Agensys' proprietary cancer targets. The agreement provides Genentech with exclusive worldwide licenses under Agensys' patent rights for the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Jul 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[A&G Pharmaceutical and MedImmune Sign Collaboration and License Agreement for Oncology Research]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_April_24/ai_85030882]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Apr 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Panacea Pharmaceuticals, Inc. and MedImmune, Inc. Sign Collaboration and License Agreement to Discover, Develop, and Commercialize Cancer Therapeutics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_April_19/ai_84925344]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 19 Apr 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
